Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.

Messina M, McCaskill-Stevens W, Lampe JW.

J Natl Cancer Inst. 2006 Sep 20;98(18):1275-84. Review.

2.

Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.

Messina MJ, Wood CE.

Nutr J. 2008 Jun 3;7:17. doi: 10.1186/1475-2891-7-17. Review.

3.

Soy for breast cancer survivors: a critical review of the literature.

Messina MJ, Loprinzi CL.

J Nutr. 2001 Nov;131(11 Suppl):3095S-108S. Review.

4.

[Soy isoflavones--a therapy for menopausal symptoms?].

Wolters M, Hahn A.

Wien Med Wochenschr. 2004 Jul;154(13-14):334-41. Review. German.

PMID:
15368955
5.

Early life and adult exposure to isoflavones and breast cancer risk.

Tomar RS, Shiao R.

J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008 Apr-Jun;26(2):113-73. doi: 10.1080/10590500802074256. Review.

PMID:
18569328
6.

Effects of soy phytoestrogens genistein and daidzein on breast cancer growth.

de Lemos ML.

Ann Pharmacother. 2001 Sep;35(9):1118-21. Review.

PMID:
11573864
7.

The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies.

Taylor CK, Levy RM, Elliott JC, Burnett BP.

Nutr Rev. 2009 Jul;67(7):398-415. doi: 10.1111/j.1753-4887.2009.00213.x. Review.

PMID:
19566600
8.

Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know.

Velentzis LS, Woodside JV, Cantwell MM, Leathem AJ, Keshtgar MR.

Eur J Cancer. 2008 Sep;44(13):1799-806. doi: 10.1016/j.ejca.2008.05.019. Epub 2008 Jul 7. Review.

PMID:
18614351
9.

Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data.

Messina M, Bennink M.

Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):707-28. Review.

PMID:
10384821
10.

Phytoestrogens and breast cancer: a complex story.

Helferich WG, Andrade JE, Hoagland MS.

Inflammopharmacology. 2008 Oct;16(5):219-26. doi: 10.1007/s10787-008-8020-0. Review.

PMID:
18815740
12.

Phytoestrogens: potential benefits and implications for breast cancer survivors.

Duffy C, Cyr M.

J Womens Health (Larchmt). 2003 Sep;12(7):617-31. Review.

PMID:
14583103
13.

Risks and benefits of dietary isoflavones for cancer.

Andres S, Abraham K, Appel KE, Lampen A.

Crit Rev Toxicol. 2011 Jul;41(6):463-506. doi: 10.3109/10408444.2010.541900. Epub 2011 Mar 26. Review.

PMID:
21438720
14.

Goitrogenic and estrogenic activity of soy isoflavones.

Doerge DR, Sheehan DM.

Environ Health Perspect. 2002 Jun;110 Suppl 3:349-53. Review.

15.

Isoflavones in breast cancer chemoprevention: where do we go from here?

Kumar N, Allen K, Riccardi D, Kazi A, Heine J.

Front Biosci. 2004 Sep 1;9:2927-34. Review.

PMID:
15353326
16.

Implications of phytoestrogen intake for breast cancer.

Duffy C, Perez K, Partridge A.

CA Cancer J Clin. 2007 Sep-Oct;57(5):260-77. Review.

17.

Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women.

Cassidy A, Albertazzi P, Lise Nielsen I, Hall W, Williamson G, Tetens I, Atkins S, Cross H, Manios Y, Wolk A, Steiner C, Branca F.

Proc Nutr Soc. 2006 Feb;65(1):76-92. Review.

PMID:
16441947
18.

Soy intake and cancer risk: a review of the in vitro and in vivo data.

Messina MJ, Persky V, Setchell KD, Barnes S.

Nutr Cancer. 1994;21(2):113-31. Review.

PMID:
8058523
19.

Soy and its isoflavones: the truth behind the science in breast cancer.

Douglas CC, Johnson SA, Arjmandi BH.

Anticancer Agents Med Chem. 2013 Oct;13(8):1178-87. Review.

PMID:
23919747
20.

Soyfoods, soybean isoflavones, and bone health: a brief overview.

Messina M, Messina V.

J Ren Nutr. 2000 Apr;10(2):63-8. Review.

PMID:
10757817
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk